Toda Pharma: French manufacturer of rapid diagnostic tests
Partager
A laboratory specialized in rapid diagnostics
Rapid tests are designed to provide guidance within minutes from a defined sample. They often rely on immunochromatographic technology and must be used according to their instructions, intended use, and applicable regulatory framework.
Toda Pharma develops and markets various references intended for health professionals, companies, institutions, and individuals according to the status of each product.
The Drugdiag® range
Drugdiag® includes saliva and urine tests targeting one or more substance families. Panels, thresholds, and reading times vary by reference.
- THC or multi-drug saliva tests for detecting recent consumption;
- urine tests in cassette, strip, or cup format;
- panels dedicated to classic substances or certain new synthetic drugs;
- solutions intended for self-monitoring, health professionals, or regulated corporate protocols.
Quality, traceability, and documentation
For a screening device, reliability does not depend solely on its geographic origin. It also depends on design, performance validation, batch control, storage conditions, and clarity of the instructions.
The documents associated with each reference must specify, in particular, the substances tested, thresholds, known cross-reactions, shelf life, and interpretation limits.
Collaboration with AMA Prévention
AMA Prévention is a specialized distributor of the Drugdiag® range and operates within the Toda Pharma environment in Strasbourg. This proximity facilitates access to technical information, management of professional requests, and after-sales support.
Our role is not just to distribute a test. We help clients choose the right matrix, the appropriate panel, and the protocol consistent with their needs, without presenting a rapid test as a laboratory analysis or a medical decision.
Who are these solutions for?
- occupational health and safety services;
- companies with designated security positions;
- health professionals and support organizations;
- local authorities, public services, and transport operators;
- individuals seeking a self-prevention tool.
